Metformin Hydrochloride
- Product NDC
- 53746-179
- 11-digit product format
- 537460179
- Labeler code
- 53746
- Product ID
- 53746-179_c6b18bc5-6548-4986-b6fc-a5f1958d5074
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metformin Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Application
- ANDA078596
- Marketing category
- ANDA
- Marketing start
- 2010-02-26
- Marketing end
- 0000-00-00
- Substance
- METFORMIN HYDROCHLORIDE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Biguanide [EPC],Biguanides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53746-179-01 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-05 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-30 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-90 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-01 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-05 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-30 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-90 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-05 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 53746-179-90 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3072-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53746-179-01 | Metformin Hydrochloride | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 14 |
| 53746-179-05 | Metformin Hydrochloride | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | | 14 |
| 53746-179-30 | Metformin Hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 14 |
| 53746-179-90 | Metformin Hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53746-179 | METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 14 | Legacy NDC, 4 package rows | 20210319_ee2739df-8db4-4b05-9a81-1590efbb589b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53746-179-01 | 53746017901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (53746-179-01) | 2010-02-26 | 0000-00-00 | No | No | Current |
| 53746-179-05 | 53746017905 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (53746-179-05) | 2010-02-26 | 0000-00-00 | No | No | Current |
| 53746-179-30 | 53746017930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (53746-179-30) | 2010-02-26 | 0000-00-00 | No | No | Current |
| 53746-179-90 | 53746017990 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (53746-179-90) | 2010-02-26 | 0000-00-00 | No | No | Current |